[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0769296T3 - Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer - Google Patents

Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer

Info

Publication number
DK0769296T3
DK0769296T3 DK96116408T DK96116408T DK0769296T3 DK 0769296 T3 DK0769296 T3 DK 0769296T3 DK 96116408 T DK96116408 T DK 96116408T DK 96116408 T DK96116408 T DK 96116408T DK 0769296 T3 DK0769296 T3 DK 0769296T3
Authority
DK
Denmark
Prior art keywords
cancer
treatment
crotonic acid
medicament
sodium
Prior art date
Application number
DK96116408T
Other languages
English (en)
Inventor
Wilfried Dr Schwab
Joerg Dr Czech
Klaus Dr Boslett
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0769296T3 publication Critical patent/DK0769296T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96116408T 1995-10-25 1996-10-14 Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer DK0769296T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19539638A DE19539638A1 (de) 1995-10-25 1995-10-25 Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen

Publications (1)

Publication Number Publication Date
DK0769296T3 true DK0769296T3 (da) 2001-10-22

Family

ID=7775689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96116408T DK0769296T3 (da) 1995-10-25 1996-10-14 Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer

Country Status (10)

Country Link
US (2) US5886033A (da)
EP (1) EP0769296B1 (da)
JP (1) JP3996658B2 (da)
AT (1) ATE202704T1 (da)
CA (1) CA2188228C (da)
DE (2) DE19539638A1 (da)
DK (1) DK0769296T3 (da)
ES (1) ES2160197T3 (da)
GR (1) GR3036754T3 (da)
PT (1) PT769296E (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2302438A1 (en) * 1997-05-19 1998-11-26 Sugen, Inc. Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
ES2166205T3 (es) * 1997-08-08 2002-04-01 Aventis Pharma Gmbh Forma cristalina de amida del acido n-(4-trifluorometilfenil)-5-metilisoxazol-4-carboxilico.
EP0933633A1 (en) * 1997-12-11 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Process for obtaining L-dihydroorotic acid and use thereof
DE19857009A1 (de) * 1998-12-10 2000-06-15 Aventis Pharma Gmbh Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7247736B2 (en) * 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
JP5064213B2 (ja) 2004-06-17 2012-10-31 インフィニティ・ディスカバリー・インコーポレイテッド Ｂｃｌタンパク質と結合パートナーとの相互作用を阻害する化合物および方法
US7842815B2 (en) 2004-06-17 2010-11-30 Infinity Pharmaceuticals, Inc. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
DE102006014165A1 (de) * 2006-03-24 2007-09-27 Schebo Biotech Ag Neue Isooxazol-Derivate und deren Verwendungen
TWI389895B (zh) 2006-08-21 2013-03-21 Infinity Discovery Inc 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
CN108472280A (zh) * 2015-09-01 2018-08-31 布罗德研究所股份有限公司 用于治疗或者预防血液癌症的化合物和方法
CN111423374B (zh) * 2020-05-18 2023-03-21 合肥工业大学 一种二氢吡唑磺酰胺类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
HU222234B1 (hu) * 1990-05-18 2003-05-28 Aventis Pharma Deutschland Gmbh. Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
DE59203828D1 (de) * 1991-10-23 1995-11-02 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease

Also Published As

Publication number Publication date
EP0769296A1 (de) 1997-04-23
ATE202704T1 (de) 2001-07-15
JPH09165336A (ja) 1997-06-24
GR3036754T3 (en) 2001-12-31
EP0769296B1 (de) 2001-07-04
DE19539638A1 (de) 1997-04-30
DE59607208D1 (de) 2001-08-09
US5886033A (en) 1999-03-23
CA2188228C (en) 2008-08-12
US6020372A (en) 2000-02-01
CA2188228A1 (en) 1997-04-26
ES2160197T3 (es) 2001-11-01
PT769296E (pt) 2001-11-30
JP3996658B2 (ja) 2007-10-24

Similar Documents

Publication Publication Date Title
DK0769296T3 (da) Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
DK0780128T3 (da) Præparat indeholdende lipoproteiner og crotonsyreamidderivater
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
NO20033765L (no) 4-Fenylpiperidinforbindelser
AU560579B2 (en) N-aromatic-n:-cycloalkylalkanoyl-piperazines
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
ES8503355A1 (es) Procedimiento de preparacion de nuevas sales de derivados organofosforados
NO953575D0 (no) Farmasöytiske forbindelser
DK0821952T3 (da) Anvendelse af isoxazol- og crotonsyreamidderivater til modulering af apoptose
DE69132578D1 (de) Cephemderivate
DK0387489T3 (da) Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider
ATE229513T1 (de) Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen
DK0417746T3 (da) N-Azabicyclo(3.3.0)octanamider af aromatiske syrer
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
ATE66475T1 (de) Aromatische thioaether.
MX9205408A (es) Metodo para tratar hipertension.
ATE199897T1 (de) Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IS1442B6 (is) Oxysalicylamido aukaafurðir